全文获取类型
收费全文 | 11527篇 |
免费 | 1240篇 |
国内免费 | 125篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 399篇 |
妇产科学 | 217篇 |
基础医学 | 1515篇 |
口腔科学 | 225篇 |
临床医学 | 1517篇 |
内科学 | 2258篇 |
皮肤病学 | 116篇 |
神经病学 | 1118篇 |
特种医学 | 390篇 |
外科学 | 1360篇 |
综合类 | 757篇 |
一般理论 | 13篇 |
预防医学 | 1151篇 |
眼科学 | 341篇 |
药学 | 758篇 |
中国医学 | 4篇 |
肿瘤学 | 655篇 |
出版年
2022年 | 102篇 |
2021年 | 216篇 |
2020年 | 134篇 |
2019年 | 183篇 |
2018年 | 288篇 |
2017年 | 175篇 |
2016年 | 180篇 |
2015年 | 170篇 |
2014年 | 259篇 |
2013年 | 464篇 |
2012年 | 505篇 |
2011年 | 509篇 |
2010年 | 336篇 |
2009年 | 285篇 |
2008年 | 460篇 |
2007年 | 578篇 |
2006年 | 546篇 |
2005年 | 543篇 |
2004年 | 481篇 |
2003年 | 447篇 |
2002年 | 449篇 |
2001年 | 420篇 |
2000年 | 415篇 |
1999年 | 376篇 |
1998年 | 183篇 |
1997年 | 147篇 |
1996年 | 180篇 |
1995年 | 144篇 |
1994年 | 113篇 |
1993年 | 131篇 |
1992年 | 288篇 |
1991年 | 271篇 |
1990年 | 290篇 |
1989年 | 243篇 |
1988年 | 219篇 |
1987年 | 241篇 |
1986年 | 193篇 |
1985年 | 152篇 |
1984年 | 152篇 |
1983年 | 130篇 |
1982年 | 99篇 |
1981年 | 65篇 |
1980年 | 68篇 |
1979年 | 109篇 |
1978年 | 98篇 |
1977年 | 83篇 |
1976年 | 71篇 |
1975年 | 73篇 |
1973年 | 56篇 |
1970年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
Antiserum raised to a factor elaborated by a lymphoblastoid cell line derived from the peripheral blood cells of an HLA-B27 positive patient with ankylosing spondylitis specifically lyses the B27 positive, but not the B27 negative, cells of ankylosing spondylitis patients. The cells of B27 positive and B27 negative normal controls are not lysed. This serum has similar specificity to antisera against cross-reactive bacteria. 相似文献
23.
24.
Margaret Sullivan Pepe Ziding Feng Gary Longton Joseph Koopmeiners 《Statistics in medicine》2009,28(5):762-779
Development of a disease screening biomarker involves several phases. In phase 2 its sensitivity and specificity is compared with established thresholds for minimally acceptable performance. Since we anticipate that most candidate markers will not prove to be useful and availability of specimens and funding is limited, early termination of a study is appropriate, if accumulating data indicate that the marker is inadequate. Yet, for markers that complete phase 2, we seek estimates of sensitivity and specificity to proceed with the design of subsequent phase 3 studies. We suggest early stopping criteria and estimation procedures that adjust for bias caused by the early termination option. An important aspect of our approach is to focus on properties of estimates conditional on reaching full study enrollment. We propose the conditional‐UMVUE and contrast it with other estimates, including naïve estimators, the well‐studied unconditional‐UMVUE and the mean and median Whitehead‐adjusted estimators. The conditional‐UMVUE appears to be a very good choice. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
25.
Nathan J Koewler Katie T Freeman Ryan J Buus Monica B Herrera Juan M Jimenez-Andrade Joseph R Ghilardi Christopher M Peters Lucy J Sullivan Michael A Kuskowski Jack L Lewis Patrick W Mantyh 《Journal of bone and mineral research》2007,22(11):1732-1742
A closed femur fracture pain model was developed in the C57BL/6J mouse. One day after fracture, a monoclonal antibody raised against nerve growth factor (anti-NGF) was delivered intraperitoneally and resulted in a reduction in fracture pain-related behaviors of approximately 50%. Anti-NGF therapy did not interfere with bone healing as assessed by mechanical testing and histomorphometric analysis. INTRODUCTION: Current therapies to treat skeletal fracture pain are limited. This is because of the side effect profile of available analgesics and the scarcity of animal models that can be used to understand the mechanisms that drive this pain. Whereas previous studies have shown that mineralized bone, marrow, and periosteum are innervated by sensory and sympathetic fibers, it is not understood how skeletal pain is generated and maintained even in common conditions such as osteoarthritis, low back pain, or fracture. MATERIALS AND METHODS: In this study, we characterized the pain-related behaviors after a closed femur fracture in the C57BL/6J mouse. Additionally, we assessed the effect of a monoclonal antibody that binds to and sequesters nerve growth factor (anti-NGF) on pain-related behaviors and bone healing (mechanical properties and histomorphometric analysis) after fracture. RESULTS: Administration of anti-NGF therapy (10 mg/kg, days 1, 6, and 11 after fracture) resulted in a reduction of fracture pain-related behaviors of approximately 50%. Attenuation of fracture pain was evident as early as 24 h after the initial dosing and remained efficacious throughout the course of fracture pain. Anti-NGF therapy did not modify biomechanical properties of the femur or histomorphometric indices of bone healing. CONCLUSIONS: These findings suggest that therapies that target NGF or its cognate receptor(s) may be effective in attenuating nonmalignant fracture pain without interfering with bone healing. 相似文献
26.
27.
28.
During the past 10 years, numerous phase I-II studies were conducted and provided clinical experience with combined radiation therapy and hyperthermia treatments. Among the rare complications reported in these combined radiation therapy-hyperthermia trials were myonecrosis and peripheral neuropathy which were felt, mainly on a clinical basis, to be caused by local heat damage. Recently, such complications were noted in two patients with recurrent prostatic cancer treated in our department with radiation therapy combined with deep regional hyperthermia delivered by the Sigma-60 applicator of the BSD 2000 hyperthermia system (Salt Lake City, UT, USA). Analysis of the results of three-dimensional modelling of the SAR (specific absorption rate, W/kg) pattern in these patients indicated high SAR at the sites of the complications. Pretreatment three-dimensional modelling or other methods of predicting potential areas of high power deposition may have a role for future hyperthermia treatment planning aiding in the prevention of possible local heat damage and providing improved delivery of heat to the target volume. 相似文献
29.
Adolf Pfefferbaum Edith V. Sullivan Margaret J. Rosenbloom Paula K. Shear Daniel H. Mathalon Kelvin O. Lim 《Psychiatry Research: Neuroimaging》1993,50(4):257-274
This cross-sectional study used a semi-automated analysis technique to quantify regional brain cerebrospinal fluid (CSF) volumes derived from computed tomography (CT) in 84 healthy men ranging from 21 to 82 years of age and 28 patients meeting Research Diagnostic Criteria for alcohol dependence. The goals were to replicate an earlier CT study of an independent sample of alcoholic and control subjects (Pfefferbaum et al., 1988a; Zipursky et al., 1988) and to compare CT assessments of brain changes with magnetic resonance imaging (MRI) assessments made in the same alcoholic patients (Pfefferbaum et al., 1992). Regional brain changes associated with normal aging were derived by regression analysis, using CT data collected from the healthy control subjects. As in the earlier CT study and in the concurrent MRI study, ventricular and sulcal CSF volumes in alcoholic patients were greater than would be expected for their age. Furthermore, the present CT study replicated the previous CT and MRI findings of a positive relationship between age and CSF volume enlargement in alcoholic patients over and above the normal age-related increase in CSF volume, suggesting greater vulnerability of the aging brain to alcohol. Comparison of CT-and MRI-derived estimates of ventricular and cortical sulcal volume revealed high correlations (>0.80). MRI and CT produced similar absolute ventricular volumes, while MRI produced larger sulcal volume estimates than did CT. The difference in sulcal volume estimate may be due to differences between CT and MRI in slice thickness and sensitivity to partial volume effects. 相似文献
30.
Synthesis and structure-activity relationships of new 9-N-alkyl derivatives of 9(S)-erythromycylamine 总被引:4,自引:0,他引:4
H A Kirst J A Wind J P Leeds K E Willard M Debono R Bonjouklian J M Greene K A Sullivan J W Paschal J B Deeter 《Journal of medicinal chemistry》1990,33(11):3086-3094
A series of new 9-N-alkyl derivatives of 9(S)-erythromycylamine has been synthesized by reductive alkylation of erythromycylamine with aliphatic aldehydes and sodium cyanoborohydride. Alternative syntheses employing hydrogenation methods have also been developed. These new 9-N-alkyl derivatives possess excellent antimicrobial activity in vitro and in vivo, especially when administered orally to treat experimental infections in mice. From structure-activity studies, 9-N-(1-propyl)erythromycylamine (LY281389) was selected as the most efficacious derivative. These methods have also been extended to the synthesis of some 9-N,N-dialkyl derivatives of erythromycylamine. 相似文献